Gout Flashcards
1
Q
Gout/Hyperuricemia
A
Allopurinol (Zyloprim) Colchicine (Colcrys) Febuxostat (Uloric) Probenecid (Benemid) Rasburicase (Elitek) Pegloticase (Krystexxa)
2
Q
Xanthine Oxidase Inhibitors
- For chronic gout
A
- Allopurinol (Zyloprim)
- Probenecid (Benemid)
- Fobuxostat (Uloric)
3
Q
Allopurinol (Zyloprim)
- Primary or secondary gout (Chronic treatment)
- Chemo pts at risk of tumor lysis syndrome (hematologic malignancies)
- Hyperuricemia in pts with recurrent calcium oxalate stones
- NOT for asymptomatic hyperuricemia
A
- MOA: Xanthine oxidase inhibitor, purine analog, reduces production of uric acid
- ADR: RASH ( can lead to SJS, d/c allopurinol w/ first sign of rash); D/N; increased LFTs; Acute gout attack (administer colchicine or NSAID upon initiation of allopurinol, w/draw once uric acid level decreased)
- DRUG INTERACTIONS: Azathioprine, 6-mercaptopurine (inhibits enzymatic inactivation, reduces dose of AZA or 6-MP); warfarin; theophyline (may increase levels)
- Aids in dissolution of tophi
- Prevents development or progression of chronic gout (keeps uric acid level below solubility limit)
- Decrease risk of permanent renal damage
- Start low, go slow (until uric acid level
4
Q
Probenecid (Benemid)
- Indicated for hyperuricemia associated with gout (chronic treatment)
- Adjuvant to PCN or ampicillin (to increase levels)
A
- MOA: Blocks renal tubular reabsorption of urate (increases uric acid excretion, decreases serum urate levels)
- Also inhibits PCN secretion (increases PCN levels)
- ADR: HA, N, worsening of gout flare, dizziness, uric acid kidney stones, blood dyscrasias
5
Q
Fobuxostat (Uloric)
- Gout chronic treatment
A
- Xanthine oxidase inhibitor
- Higher rate of CV events than with allopurinol
- Hepatic failure reported (measure LFTs at baseline and monitor during treatment)
- NO RENAL adjust
6
Q
Lesinurad (Zurampic)
- Indicated for use with a XOI when target uric levels not achieved (NOT for monotherapy)
A
- MOA: blocks uric acid reabsorption
- ADR: Increased sCr, renal failure, kidney stones; HA, flu, GERD
- DRUG INTERACTIONS: metabolized by CYP 2C9, weak induce of 3A4 (may reduce efficacy of amlodipine, sildenafil)
7
Q
Uric acid lowering agents
A
- Colchicine (Colcrys)
- Pegloticase (Krystexxa)
8
Q
Colchicine (Colcrys)
- Prophylaxis and treatment of ACUTE gout flares
- Familial mediterranean fever
A
- MOA not well known (inhibits microtubule formation in bone cells and prevents neutrophil activation)
- Narrow therapeutic window
- ADR: DIARRHEA!!!!!!; Throat pain
- WARNING: blood dyscrasias, neuromuscular toxicity and rhabdomyolysis (increased risk in elderly and renal insufficiency); PGP (cyclosporine, ranolazine) and CYP 3A4 substrate (contraindicated with strong 3A4 inhibitors– ketoconazole, ritonavir, clarithromycin)
- RENAL adjust
9
Q
Pegloticase (Krystexxa)
- For refractory chronic gout
A
- PEGylated uricase enzyme
- Catalyzes oxidation of uric acid to allantoin
- COMMON ADR: gout flare, infusion rxn, N/V/C, ecchymosis, nasopharyngitis, chest pain, CHF exacerbation
- Given IV (risk of anaphylaxis and infusion rxn– MUST be given in infusion center, requires premed w/ antihistamines– benedryl and corticosteroids)
10
Q
Rasburicase (Elitek)
- For hyperuricemia due to tumor lysis syndrome
A
- Recombinant urate-oxidase
- Catalyzes enzyme oxidation of uric acid into allantoin
- ADR: anaphylaxis, hemolysis, methemoglobinemia
11
Q
Acute Gout guideline
A
- Acute gouty arthritis attacks should be treated w/ pharmacologic therapy
- To provide optimal care, treatment should be initiated w/in 24 hrs of acute gout attack onset
- Ongoing ULT should NOT be interrupted during an acute gout attack
- NSAIDs (or COX-2 inhibitor); systemic corticosteroids; colchicine
12
Q
Prophylaxis
A
- With or just prior to initiating ULT (urate lowering therapy)
- First line: low dose colchicine OR low dose NSAIDs
- Second line: low dose prednisone/prednisolone
13
Q
Hyperuricemia/Chronic Gout
A
- Pt education: diet, lifestyle, treatment objectives, management of comorbid conditions
- First line pharmacologic ULT in gout: XOI therapy (allopurinol or febuxostat)
- Target serum urate level